Plant-made pharmaceuticals for exposure to chemical weapons
US Capital Global has been engaged by Canadian biotech firm developing plant-made pharmaceuticals for exposure to chemical weapons, such as sarin gas and ricin, currently working with the Departments of Defense of the U.K., Canada, and Australia. |
|